LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.72
-1.18 (-4.23%)
At close: Dec 5, 2025, 4:00 PM EST
26.71
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:56 PM EST
LENZ Therapeutics Revenue
LENZ Therapeutics had revenue of $12.50M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $17.50M.
Revenue (ttm)
$17.50M
Revenue Growth
n/a
P/S Ratio
42.64
Revenue / Employee
$1,590,909
Employees
11
Market Cap
836.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.00M | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLENZ News
- 1 day ago - LENZ Therapeutics, Inc. (LENZ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 days ago - LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia - GlobeNewsWire
- 10 days ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - LENZ Therapeutics, Inc. (LENZ) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025 - GlobeNewsWire
- 2 months ago - LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States - PRNewsWire
- 2 months ago - LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States - GlobeNewsWire